OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Chest Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations	134
Indoor Air Pollution and Respiratory Health	62
Silicosis: An Update and Guide for Clinicians	50
Epidemiology of Chronic Obstructive Pulmonary Disease	48
Allergic Bronchopulmonary Aspergillosis	47
Advances in the Treatment of Non–Small Cell Lung Cancer	47
Multimorbidity in Patients with Chronic Obstructive Pulmonary Disease	38
Pneumothorax	28
Working in Smoke:	28
Diagnosis of Primary Ciliary Dyskinesia	27
Sex Differences in Pulmonary Hypertension	24
The Respiratory Risks of Ambient/Outdoor Air Pollution	22
Pleural Tuberculosis	21
Coal Workers’ Pneumoconiosis and Other Mining-Related Lung Disease	21
Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension	20
Alpha-1 Antitrypsin Deficiency Associated COPD	16
Advances in Treatment of Locally Advanced or Metastatic Non–Small Cell Lung Cancer	16
Advances in the Treatment of Stage III Non–Small Cell Lung Cancer	16
Biomarkers in Chronic Obstructive Pulmonary Disease	15
Pulmonary Hypertension in Left Heart Disease	14
Parapneumonic Effusion and Empyema	14
Respiratory Health Effects of Exposure to Cleaning Products	14
The Changing Nature of Wildfires	14
Adaptation and Maladaptation of the Right Ventricle in Pulmonary Vascular Diseases	13
The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation	13

Sex Differences in Obstructive Sleep Apnea	13
Screening for Occupational Lung Cancer	13
Pleural Fluid Analysis	13
Congenital Heart Disease-Associated Pulmonary Hypertension	13
Alternatives to Surgery for Early-Stage Non–Small Cell Lung Cancer	13
Gender Differences in Critical Illness and Critical Care Research	12
Smoking Cessation/Vaccinations	12
Chylothorax and Pseudochylothorax	12
Lung Function Testing in Chronic Obstructive Pulmonary Disease	11
Nontuberculous Mycobacteria	10
Microbiology and the Microbiome in Bronchiectasis	10
Health Disparities in Environmental and Occupational Lung Disease	10
Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease	9
Women and Lung Cancer	9
Bronchiectasis in Childhood	9
Sleep Deficiency and Cardiometabolic Disease	9
Interstitial Lung Disease in 2020	9
Nontuberculous Mycobacterial Infections in Cystic Fibrosis	9
The Need for Social and Environmental Determinants of Health Research to Understand and Intervene on Racial/Ethnic Disparities in Obstructive Sleep Apnea	9
Occupational Contributions to Interstitial Lung Disease	9
Management of Connective Tissue Disease-Associated Interstitial Lung Disease	8
The Role of Exercise Testing in Pulmonary Vascular Disease	8
Challenges Faced by Women with Cystic Fibrosis	8
Occupational Bronchiolitis	8
Differences Between Men and Women with Chronic Obstructive Pulmonary Disease	8
Management of Malignant Pleural Effusions	8
Update on Innate and Adaptive Immunity in Cystic Fibrosis	8
Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease	8
Medical Thoracoscopy	8
Supporting Professionals in Critical Care Medicine	7
Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era	7
Future Directions in Bronchiectasis Research	7
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease	7
Update on Climate Change	7
Sleep Deficiency in Young Children	7
Management of Idiopathic Pulmonary Fibrosis	7
Sleep Deficiency	7
Bronchiectasis and Chronic Obstructive Pulmonary Disease Overlap Syndrome	7
Preoperative Assessment and Perioperative Management of the Patient with Pulmonary Vascular Disease	7
Clinical Relevance and Management of “Pre–Interstitial Lung Disease”	7
Diagnosis and Evaluation of Bronchiectasis	7
Patient-Centered and Family-Centered Care in the Intensive Care Unit	7
Sleep Deficiency, Sleep Apnea, and Chronic Lung Disease	7
Integrative Omics to Characterize and Classify Pulmonary Vascular Disease	7
Pulmonary Arterial Hypertension Secondary to Drugs and Toxins	6
Pulmonary Considerations for Pregnant Women	6
Survivorship After Critical Illness and Post-Intensive Care Syndrome	6
Diagnosis and Management of Fibrotic Interstitial Lung Diseases	6
Breaking the Impasse	6
Pulmonary Hypertension in Pregnancy	6

Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis	6
Systemic Medications in Chronic Obstructive Pulmonary Disease	6
Alternatives to Surgery for Early-Stage Non–Small Cell Lung Cancer	6
Lung Cancer Staging	6
Surgical Therapies for Chronic Obstructive Pulmonary Disease	6
Management of Mental Health in Cystic Fibrosis	6
Management of Pneumothorax	6
SARS-CoV-2 Infection and COVID-19 in Children	6
Chronic Obstructive Pulmonary Disease Pathogenesis	6
Sex Differences and the Role of Sex Hormones in Pulmonary Hypertension	6
Malignant Pleural Effusions	6
Diagnostic Classification of Interstitial Lung Disease in Clinical Practice	6
Family Planning and Reproductive Health in Cystic Fibrosis	6
Pulmonary Rehabilitation	6
Lung Transplant Procedure of Choice	5
Advances in Ventilator Management for Patients with Acute Respiratory Distress Syndrome	5
Indoor Microbial Exposures and Chronic Lung Disease	5
Sleep Deficiency in the Elderly	5
Indwelling Pleural Catheters	5
Bronchiectasis from 2012 to 2022	5
The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections	5
Prevention of Chronic Obstructive Pulmonary Disease	5
Group 3 Pulmonary Hypertension	5
Management of Oligometastatic Disease in Advanced Non–Small Cell Lung Cancer	5
Interstitial Lung Diseases and the Impact of Gender	5
Coronavirus Disease-2019 in the Immunocompromised Host	5
Palliative Care in Lung Cancer	5
Chest Imaging in the Diagnosis of Occupational Lung Diseases	5